Inactive Instrument

Press Releases LivaNova PLC London S.E.

Equities

LivaNova: Q1 Earnings Snapshot	06:12am	AQ
LivaNova Reports First-Quarter 2024 Results	06:02am	BU
LivaNova Announces Ahmet Tezel, Ph.D., as Chief Innovation Officer	Apr. 30	BU
LivaNova : 2023 UK Annual Report	Apr. 26	PU
LivaNova : 2024 Proxy Statement and Notice of Annual General Meeting	Apr. 26	PU
LivaNova Issues Notice to U.S. Patients Regarding Cybersecurity Incident	Apr. 25	BU
LivaNova to Announce First-Quarter 2024 Results	Mar. 21	BU
LivaNova Announces a Positive Predictive Outcome of Trial Success in its OSPREY Clinical Study for Moderate to Severe Obstructive Sleep Apnea	Mar. 20	BU
LivaNova Announces Pricing of Private Offering of $300 Million of 2.50% Convertible Senior Notes Due 2029	Mar. 05	BU
LivaNova Announces Proposed Private Offering of $300 Million of Convertible Senior Notes	Mar. 04	BU
LivaNova to Present at the Barclays Global Healthcare Conference	Mar. 04	BU
LivaNova: Q4 Earnings Snapshot	Feb. 21	AQ
LivaNova Reports Fourth-Quarter and Full-Year 2023 Results	Feb. 21	BU
LivaNova Announces Vladimir A. Makatsaria as CEO and Board Director	Feb. 05	BU
LivaNova to Wind Down Advanced Circulatory Support Business Unit	Jan. 08	BU
LivaNova to Announce Fourth-Quarter and Full-Year 2023 Results	Jan. 04	BU
LivaNova to Present at the Piper Sandler Healthcare Conference	Nov. 09	BU
LivaNova : 3Q 2023 Earnings Infographic	Nov. 01	PU
LivaNova: Q3 Earnings Snapshot	Nov. 01	AQ
LivaNova Reports Third-Quarter 2023 Results	Nov. 01	BU

No results for this search